Loading [Contrib]/a11y/accessibility-menu.js
  • Menu
  • Articles
    • Correspondence
    • Errata
    • From the NCIOM
    • Letters to the Editor
    • Original Research
    • Policy Forum: Columns
    • Policy Forum: Introduction
    • Policy Forum: Invited Commentaries & Sidebars
    • Policy Forum: Issue Brief
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Subscribe
  • search

    Sorry, something went wrong. Please try your search again.
    ×

    • Articles
    • Blog posts

RSS Feed

Enter the URL below into your favorite RSS reader.

https://ncmedicaljournal.com/feed
×
Policy Forum: Invited Commentaries & Sidebars
Vol. 74, Issue 6, 2013November 01, 2013 EDT

Direct-to-Consumer Genomic Testing Offers Little Clinical Utility but Appears to Cause Minimal Harm

Stacie D. Adams, James P. Evans, Arthur S. Aylsworth,
Invited Commentary
• https://doi.org/10.18043/ncm.74.6.494
Adams, Stacie D., James P. Evans, and Arthur S. Aylsworth. 2013. “Direct-to-Consumer Genomic Testing Offers Little Clinical Utility but Appears to Cause Minimal Harm.” North Carolina Medical Journal 74 (6): 494–99. https://doi.org/10.18043/ncm.74.6.494.
Save article as...▾
  • PDF
  • XML
  • Citation (BibTeX)

View more stats

Powered by Scholastica, the modern academic journal management system